A study from the University of Kentucky suggests that the experimental drug MW150 may help reduce inflammation during alcohol withdrawal, potentially benefiting individuals with alcohol use disorder. The research emphasizes the need for further studies to confirm these findings and explore the drug's interactions with alcohol.
Our neutral summary
A study from the University of Kentucky suggests that the experimental drug MW150 may help reduce inflammation during alcohol withdrawal, potentially benefiting individuals with alcohol use disorder. The research emphasizes the need for further studies to confirm these findings and explore the drug's interactions with alcohol.
The reporting belongs to Fox News — Latest; we don't reproduce it.
No note attached
on this article.
Experimental Alzheimer’s drug could reduce alcohol withdrawal damage, researchers say
Research on Experimental Drug MW150 Suggests Potential Benefits for Alcohol Withdrawal